62 products added to the February 2021 Discount Not Deducted (DND) list

62 products added to the February 2021 Discount Not Deducted (DND) list

January 27, 2021

Following applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 62 new products will enter the list of ‘Drugs for which Discount is Not Deducted’ (DND) in Part II of the Drug Tariff from 1 February 2021. This takes the total number of products granted DND status over the past 12 months to over 250 following checks made by PSNC.

Pradaxa 75mg /150mg capsules, Ursofalk 500mg tablets and Salofalk 1g/application foam enema are among the new products added to the DND list to which the discount deduction scale will no longer apply from February 2021.

Click here to view the 62 products added to DND list on 1st February 2021:

  • Alimemazine 10mg tablets
  • Alimemazine 7.5mg/5ml oral solution
  • Alkindi 0.5mg granules in capsules for opening
  • Alkindi 1mg granules in capsules for opening
  • Alkindi 2mg granules in capsules for opening
  • Alkindi 5mg granules in capsules for opening
  • Altraplen Compact Starter Pack liquid
  • Altraplen Protein liquid
  • Altraplen Protein Starter Pack liquid
  • Altrashot 120ml bottles
  • Altrashot Starter Pack liquid
  • Beclometasone 0.025% cream
  • Beclometasone 0.025% ointment
  • Betamethasone valerate 0.1% / Clioquinol 3% cream
  • Betamethasone valerate 0.1% / Clioquinol 3% ointment
  • Betamethasone valerate 0.1% / Neomycin 0.5% cream
  • Betamethasone valerate 0.1% / Neomycin 0.5% ointment
  • Calcium Resonium powder
  • Carbamazepine 125mg suppositories
  • Carbamazepine 250mg suppositories
  • Chloral hydrate 143.3mg/5ml oral solution BP
  • Colomycin 2million unit powder for solution for injection vials
  • Dicycloverine 10mg tablets
  • Dicycloverine 10mg/5ml oral solution
  • Dicycloverine 20mg tablets
  • Epilim Chronosphere MR 100mg granules sachets
  • Epilim Chronosphere MR 250mg granules sachets
  • Epilim Chronosphere MR 500mg granules sachets
  • Epilim Chronosphere MR 50mg granules sachets
  • Epilim Intravenous 400mg powder and solvent for solution for injection vials
  • Erastig 13.3mg/24hours transdermal patches
  • Griseofulvin 125mg tablets
  • Halkid 200micrograms/ml oral solution
  • Jorveza 1mg orodispersible tablets
  • Lithium carbonate 250mg tablets
  • Multaq 400mg tablets
  • Nalcrom 100mg capsules
  • Neostigmine 15mg tablets
  • Neotigason 25mg capsules
  • Nitrazepam 2.5mg/5ml oral suspension
  • Norgalax 120mg/10g enema
  • Nutricrem dessert
  • Nutricrem Starter Pack dessert
  • Octasa 1600mg MR gastro-resistant tablets
  • Pentacarinat 300mg powder for solution for injection vials
  • Phosphates enema (Formula B) 128ml long tube
  • Pradaxa 150mg capsules
  • Pradaxa 75mg capsules
  • Resonium A powder
  • Sabril 500mg oral powder sachets
  • Salofalk 1g gastro-resistant tablets
  • Salofalk 1g/application foam enema
  • Solian 100 tablets
  • Solian 100mg/ml oral solution
  • Syrisal 292.5mg/5ml (1mmol/ml) oral solution
  • Testosterone enantate 250mg/1ml solution for injection ampoules
  • Thamicarb 84mg/1ml oral solution
  • Ursofalk 250mg capsules
  • Ursofalk 500mg tablets
  • Vanquoral 100mg capsules
  • Vanquoral 50mg capsules
  • Xonvea 10mg/10mg gastro-resistant tablets

For a list of all the monthly changes to the DND status of products please see the following page Notice of changes to discount not deducted (DND) status of products.


Background

The DND list is updated monthly by the DHSC and includes grouped and individual items. Individual items are separately listed in Part II of the Drug Tariff. Any items covered by the ‘Group Items’ heading are not listed again individually in Part II. Contractors can also check the Actual Medicinal Product (AMP) listing on Dictionary of Medicines and Devices (dm+d) to identify whether a product meets the DND criteria (see below).

Group items

Any products that are covered by one or more of the Group items categories below are reimbursed without any discount deduction applied.

  • Cold Chain Storage (ALL)
  • Schedule 1, 2 or 3 Controlled Drugs: Products containing drugs listed in Schedules 1, 2 and 3 of the Misuse of Drugs Regulation 2001
  • Cytotoxic or Cytostatic item (ALL):
  • Immunoglobulins (ALL)
  • Insulins for injection (ALL)
  • Vaccines and antisera (ALL)
  • Unlicensed medicines: ‘Specials’ not listed in Part VIIIB where the product has been sourced from a supplier holding a MHRA specials or importers licence (prescriptions must be endorsed with invoice price less discount/rebate)
  • Hazardous chemicals

Individual items  

Products that do not are covered by one or more of the Group item categories above must fulfil all three of the following criteria to qualify for entry to the DND list.

  • the manufacturer(s), AAH and Alliance do not offer pharmacy contractors a discount
  • fewer than 500,000 items per year are dispensed of the product
  • average net ingredient cost (NIC) per item is more than £50

PSNC will continue its work to assess whether other drugs and appliances fulfil the current DND entry requirements under either the ‘Group’ and ‘Individual item’ criteria and make applications to NHSBSA and DHSC, accordingly.

If a product is currently subject to the discount deduction scale and you believe that it should be added to DND list based on the criteria specified above, please contact the PSNC Dispensing and Supply Team by emailing info@psnc.org.uk who will investigate whether the product meets the relevant DND criteria and make an application to the DHSC and NHSBSA, as appropriate.

For further information on how discount deduction works, click here



Posted in: , ,


More Latest News >